Insider Trading disclosures for Biofrontera Inc

The latest disclosure was made by Eugene Fredrick Leffler in Biofrontera Inc where a trade of 175,000 Employee stock option (right to buy) done was reported to US exchanges on July 12, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Show

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Value	Security Type
Eugene Fredrick Leffler	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jul 2024	175,000	180,000	-	-	Employee stock option (right to buy)
John J. Borer	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jul 2024	20,000	21,100	-	-	Employee stock option (right to buy)
Eugene Fredrick Leffler	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jul 2024	175,000	175,000	-	-	Restricted Stock Units
Kevin D. Weber	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jul 2024	20,000	21,100	-	-	Employee stock option (right to buy)
Beth J. Hoffman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jul 2024	20,000	21,100	-	-	Employee stock option (right to buy)
Hermann Luebbert	Director, CEO & Chairman	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jul 2024	275,000	275,000	-	-	Restricted Stock Units
Hermann Luebbert	Director, CEO & Chairman	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jul 2024	275,000	290,211	-	-	Employee stock option (right to buy)
Heikki Lanckriet	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jul 2024	20,000	20,000	-	-	Employee stock option (right to buy)
Hermann Luebbert	Director, CEO & Exec. Chairman	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 May 2024	4,771	15,211	-	-	Common Stock
Hermann Luebbert	Director, CEO & Exec. Chairman	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 May 2024	4,771	0	-	-	Restricted Stock Units
Erica Monaco	Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 May 2023	76,336	76,336	-	-	Restricted Stock Units
Hermann Luebbert	Director, Executive Chairman	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 May 2023	95,420	95,420	-	-	Restricted Stock Units
Hermann Luebbert	Director, Executive Chairman	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 May 2023	95,420	208,799	-	-	Common Stock
Erica Monaco	Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 May 2023	76,336	133,025	-	-	Common Stock
Eugene Fredrick Leffler	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2023	100,000	100,000	-	-	Employee stock option (right to buy)
Hermann Lubbert	Director, Executive Chairman	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	22 Aug 2022	113,379	113,379	-	-	Common Stock
Hermann Lubbert	Director, Executive Chairman	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	22 Aug 2022	113,379	190,840	-	-	Restricted Stock Units
Erica Monaco	Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jul 2022	56,689	56,689	-	-	Common Stock
Erica Monaco	Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jul 2022	56,689	152,672	-	-	Restricted Stock Units
Erica Monaco	Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 May 2022	152,672	209,361	-	-	Employee stock option (right to buy)
Erica F. Gates	Senior Director Finance	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 May 2022	19,084	39,492	-	-	Employee stock option (right to buy)
Beth J. Hoffman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 May 2022	22,000	22,000	-	-	Employee stock option (right to buy)
Loretta M. Wedge	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 May 2022	22,000	22,000	-	-	Employee stock option (right to buy)
Erica Monaco	Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 May 2022	152,672	209,361	-	-	Restricted Stock Units
Hermann Lubbert	Director, Executive Chairman	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 May 2022	190,840	304,219	-	-	Employee stock option (right to buy)
Kevin D. Weber	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 May 2022	22,000	22,000	-	-	Employee stock option (right to buy)
John J. Borer	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 May 2022	22,000	22,000	-	-	Employee stock option (right to buy)
Hermann Lubbert	Director, Executive Chairman	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 May 2022	190,840	304,219	-	-	Restricted Stock Units
Erica Monaco	Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Dec 2021	56,689	56,689	-	-	Employee stock option (right to buy)
Erica Monaco	Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Dec 2021	56,689	56,689	-	-	Restricted Stock Units
Erica F. Gates	Controller	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Dec 2021	20,408	20,408	-	-	Employee stock option (right to buy)

Showing 1 to 31 of 31 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

New 52W Low in past week

High volume+gain today

Insider Trading disclosures for Biofrontera Inc

The latest disclosure was made by Eugene Fredrick Leffler in Biofrontera Inc where a trade of 175,000 Employee stock option (right to buy) done was reported to US exchanges on July 12, 2024.

Screeners based on Insider Trading and SAST parameters